336 related articles for article (PubMed ID: 27898698)
21. PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Mukhopadhyay P; Horváth B; Rajesh M; Varga ZV; Gariani K; Ryu D; Cao Z; Holovac E; Park O; Zhou Z; Xu MJ; Wang W; Godlewski G; Paloczi J; Nemeth BT; Persidsky Y; Liaudet L; Haskó G; Bai P; Boulares AH; Auwerx J; Gao B; Pacher P
J Hepatol; 2017 Mar; 66(3):589-600. PubMed ID: 27984176
[TBL] [Abstract][Full Text] [Related]
22. Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease.
Wu Y; Ma KL; Zhang Y; Wen Y; Wang GH; Hu ZB; Liu L; Lu J; Chen PP; Ruan XZ; Liu BC
Liver Int; 2016 Oct; 36(10):1525-34. PubMed ID: 27028410
[TBL] [Abstract][Full Text] [Related]
23. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
24. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease.
Luo W; Xu Q; Wang Q; Wu H; Hua J
Sci Rep; 2017 Mar; 7():44612. PubMed ID: 28300213
[TBL] [Abstract][Full Text] [Related]
25. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
Lytle KA; Wong CP; Jump DB
PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
[TBL] [Abstract][Full Text] [Related]
26. c-Met Signaling Protects from Nonalcoholic Steatohepatitis- (NASH-) Induced Fibrosis in Different Liver Cell Types.
Drescher HK; Schumacher F; Schenker T; Baues M; Lammers T; Hieronymus T; Trautwein C; Streetz KL; Kroy DC
Oxid Med Cell Longev; 2018; 2018():6957497. PubMed ID: 30538805
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice.
Hoo RL; Lee IP; Zhou M; Wong JY; Hui X; Xu A; Lam KS
J Hepatol; 2013 Feb; 58(2):358-64. PubMed ID: 23108115
[TBL] [Abstract][Full Text] [Related]
28. Lactobacillus paracasei Induces M2-Dominant Kupffer Cell Polarization in a Mouse Model of Nonalcoholic Steatohepatitis.
Sohn W; Jun DW; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
Dig Dis Sci; 2015 Nov; 60(11):3340-50. PubMed ID: 26143342
[TBL] [Abstract][Full Text] [Related]
29. Electronegative LDL is linked to high-fat, high-cholesterol diet-induced nonalcoholic steatohepatitis in hamsters.
Lai YS; Yang TC; Chang PY; Chang SF; Ho SL; Chen HL; Lu SC
J Nutr Biochem; 2016 Apr; 30():44-52. PubMed ID: 27012620
[TBL] [Abstract][Full Text] [Related]
30. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization.
Liu K; Zhao E; Ilyas G; Lalazar G; Lin Y; Haseeb M; Tanaka KE; Czaja MJ
Autophagy; 2015; 11(2):271-84. PubMed ID: 25650776
[TBL] [Abstract][Full Text] [Related]
31. Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression.
Kim AD; Kui L; Kaufmann B; Kim SE; Leszczynska A; Feldstein AE
J Mol Med (Berl); 2023 Jul; 101(7):813-828. PubMed ID: 37166517
[TBL] [Abstract][Full Text] [Related]
32. Lipocalin-2 mediates non-alcoholic steatohepatitis by promoting neutrophil-macrophage crosstalk via the induction of CXCR2.
Ye D; Yang K; Zang S; Lin Z; Chau HT; Wang Y; Zhang J; Shi J; Xu A; Lin S; Wang Y
J Hepatol; 2016 Nov; 65(5):988-997. PubMed ID: 27266617
[TBL] [Abstract][Full Text] [Related]
33. CXC chemokine receptor 3 promotes steatohepatitis in mice through mediating inflammatory cytokines, macrophages and autophagy.
Zhang X; Han J; Man K; Li X; Du J; Chu ES; Go MY; Sung JJ; Yu J
J Hepatol; 2016 Jan; 64(1):160-70. PubMed ID: 26394162
[TBL] [Abstract][Full Text] [Related]
34. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.
Shiri-Sverdlov R; Wouters K; van Gorp PJ; Gijbels MJ; Noel B; Buffat L; Staels B; Maeda N; van Bilsen M; Hofker MH
J Hepatol; 2006 Apr; 44(4):732-41. PubMed ID: 16466828
[TBL] [Abstract][Full Text] [Related]
35. Sparstolonin B attenuates early liver inflammation in experimental NASH by modulating TLR4 trafficking in lipid rafts via NADPH oxidase activation.
Dattaroy D; Seth RK; Das S; Alhasson F; Chandrashekaran V; Michelotti G; Fan D; Nagarkatti M; Nagarkatti P; Diehl AM; Chatterjee S
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G510-25. PubMed ID: 26718771
[TBL] [Abstract][Full Text] [Related]
36. Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization.
Jiang K; Lu S; Li D; Liu M; Jin H; Lei B; Wang S; Long K; He S; Zhong F
J Gastroenterol; 2023 Sep; 58(9):894-907. PubMed ID: 37227481
[TBL] [Abstract][Full Text] [Related]
37. Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation.
Reid DT; Reyes JL; McDonald BA; Vo T; Reimer RA; Eksteen B
PLoS One; 2016; 11(7):e0159524. PubMed ID: 27454866
[TBL] [Abstract][Full Text] [Related]
38. Lack of interleukin-1α in Kupffer cells attenuates liver inflammation and expression of inflammatory cytokines in hypercholesterolaemic mice.
Olteanu S; Kandel-Kfir M; Shaish A; Almog T; Shemesh S; Barshack I; Apte RN; Harats D; Kamari Y
Dig Liver Dis; 2014 May; 46(5):433-9. PubMed ID: 24582082
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of Extracellular Cathepsin D Reduces Hepatic Lipid Accumulation and Leads to Mild Changes in Inflammationin NASH Mice.
Yadati T; Houben T; Bitorina A; Oligschlaeger Y; Gijbels MJ; Mohren R; Lütjohann D; Khurana P; Goyal S; Kulkarni A; Theys J; Cillero-Pastor B; Shiri-Sverdlov R
Front Immunol; 2021; 12():675535. PubMed ID: 34335574
[TBL] [Abstract][Full Text] [Related]
40. HSPA12A Is a Novel Player in Nonalcoholic Steatohepatitis via Promoting Nuclear PKM2-Mediated M1 Macrophage Polarization.
Kong Q; Li N; Cheng H; Zhang X; Cao X; Qi T; Dai L; Zhang Z; Chen X; Li C; Li Y; Xue B; Fang L; Liu L; Ding Z
Diabetes; 2019 Feb; 68(2):361-376. PubMed ID: 30455376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
